Latest News & Updates

Breaking News

  • 11 hours ago

  • Vaibhavi M.

Moderna Reaches $950M Global Settlement With Arbutus And Genevant, Resolving Vaccine Patent Litigation
Breaking News
Teva And Blackstone Life Sciences Sign $400M Deal To Advance Phase 3 TL1A Antibody Duvakitug

Vaibhavi M.

Other trending news you may like to read

Moderna Reaches $950M Global Settlement With Arbutus And Genevant, Resolving Vaccine Patent Litigation

Moderna settles Arbutus, Genevant patent litigation for $950M.

Vaibhavi M.

Pharma Now

Teva And Blackstone Life Sciences Sign $400M Deal To Advance Phase 3 TL1A Antibody Duvakitug

Teva secures $400M from Blackstone to advance Phase 3 TL1A mAb duvakitug.

Vaibhavi M.

Pharma Now

GSK Finalises $2.2 Billion Acquisition Of RAPT Therapeutics To Advance Long-Acting Anti-IgE Therapy, Expands Allergy Pipeline With Ozureprubart

GSK closes $2.2B RAPT deal, adds Phase IIb anti-IgE ozureprubart.

Vaibhavi M.

Pharma Now

Acadia Pharmaceuticals Appoints Vertex Finance Leader Jonathan Poole To Board Of Directors, Strengthening Financial And Audit Oversight

Acadia adds Vertex finance SVP Jonathan Poole to board, Audit Committee.

Vaibhavi M.

Pharma Now